LAMAZYM

( DrugBank: Lamazym / KEGG DRUG: Velmanase alfa )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
19	ライソゾーム病	23

19. ライソゾーム病

臨床試験数 : 899 / 薬物数 : 684 - (DrugBank : 99) / 標的遺伝子数 : 51 - 標的パスウェイ数 : 182

trials per page:

Showing 1 to 10 of 23 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02998879 (ClinicalTrials.gov)	December 2016	25/11/2016	Trial on Safety and Efficacy of Velmanase Alfa Treatment in Pediatric Patients With Alpha-Mannosidos ...	A 24-month Multicenter, Open-label Phase II Trial Investigating the Safety and Efficacy of Repeated ...	Alpha-Mannosidosis	Drug: Velmanase Alfa (e.g. Lamazym)	Chiesi Farmaceutici S.p.A.	Cromsource	Completed	N/A	6 Years	All	5	Phase 2	Austria;Denmark;France;Germany;Italy
2	NCT02478840 (ClinicalTrials.gov)	February 2015	9/2/2015	Evaluation of Long-term Efficacy of Treatment With Lamazym	A Single Center, Open Label Clinical Trial Investigating the Long-term Efficacy of rhLAMAN (Recombin ...	Alpha-Mannosidosis	Drug: Lamazym	Zymenex A/S	NULL	Completed	N/A	N/A	All	18	Phase 3	Denmark
3	EUCTR2013-000336-97-DK (EUCTR)	30/01/2015	03/12/2014	A trial of the long-term safety of Lamazymaftercare treatment of subjects with alpha-Mannosidosis wh ...	A multi-center, un-controlled, open-labeled trial of the long-term safety of Lamazymaftercare treatm ...	Alpha-Mannosidosis MedDRA version: 20.0;Level: LLT;Classification code 10032658;Term: Other specifie ...	Product Name: Lamazym Product Code: rhLAMAN INN or Proposed INN: Velmanase alfa Other descriptive name: ...	Chiesi Farmaceutici S.p.A.	NULL	Not Recruiting			Female: yes Male: yes	13	Phase 3	France;Denmark
4	EUCTR2014-003950-15-DK (EUCTR)	22/01/2015	25/11/2014	Medical research trial for testing drug treatment of alpha-Mannosidosis	A single center, open label clinical trial investigating the long-term efficacy of rhLAMAN (recombin ...	alpha-Mannosidosis MedDRA version: 17.1;Level: LLT;Classification code 10032658;Term: Other specifie ...	Product Name: Lamazym Product Code: rhLAMAN INN or Proposed INN: recombinant human lysosomal alpha-man ...	Zymenex A/S	NULL	Not Recruiting			Female: yes Male: yes			Denmark
5	NCT01908712 (ClinicalTrials.gov)	August 2013	16/7/2013	Lamazym Aftercare Study FR Designed to Provide Treatment for French Patients	A Multi-center, Un-controlled, Open-labeled Trial of the Long-term Safety of LamazymAftercare Treatm ...	Alpha-Mannosidosis	Drug: Lamazym	Chiesi Farmaceutici S.p.A.	NULL	Completed	N/A	N/A	All	13	Phase 3	France
6	EUCTR2012-000979-17-SE (EUCTR)	30/07/2013	07/06/2013	A Placebo-Controlled phase 3 trial of repeated Lamazym treatment of subjects with Alpha-Mannosidosis	A Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel Group Trial, Investigating th ...	Treatement of Alpha-Mannosidosis;Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases ...	Product Name: Lamazym Product Code: rhLAMAN INN or Proposed INN: Lamazym Other descriptive name: recomb ...	Zymenex A/S	NULL	Not Recruiting			Female: yes Male: yes	25	Phase 3	Spain;Belgium;Denmark;Germany;Sweden
7	EUCTR2013-000336-97-FR (EUCTR)	26/06/2013	28/09/2015	A trial of the long-term safety of Lamazymaftercare treatment of subjects with alpha-Mannosidosis wh ...	A multi-center, un-controlled, open-labeled trial of the long-term safety of Lamazymaftercare treatm ...	Treatment of Alpha-Mannosidosis;Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases ...	Product Name: Lamazym Product Code: rhLAMAN INN or Proposed INN: recombinant human lysosomal alpha-man ...	Zymenex A/S	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	7	Phase 3	France;Denmark
8	NCT01908725 (ClinicalTrials.gov)	June 2013	12/6/2013	Lamazym Aftercare Study	A Single-center, Un-controlled, Open-labeled Trial of the Long-term Safety of LamazymAftercare Treat ...	Alpha-Mannosidosis	Drug: Lamazym	Chiesi Farmaceutici S.p.A.	NULL	Completed	N/A	N/A	All	8	Phase 3	Denmark
9	EUCTR2012-000979-17-BE (EUCTR)	26/03/2013	07/01/2013	A Placebo-Controlled phase 3 trial of repeated Lamazym treatment of subjects with Alpha-Mannosidosis	A Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel Group Trial, Investigating th ...	Treatement of Alpha-Mannosidosis;Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases ...	Product Name: Lamazym Product Code: rhLAMAN INN or Proposed INN: recombinant human alpha-mannosidase Ot ...	Zymenex A/S	NULL	Not Recruiting			Female: yes Male: yes	25	Phase 3	Spain;Belgium;Denmark;Germany;Sweden
10	EUCTR2012-000979-17-ES (EUCTR)	27/02/2013	09/01/2013	A Placebo-Controlled phase 3 trial of repeated Lamazym treatment of subjects with Alpha-Mannosidosis	A Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel Group Trial, Investigating th ...	Treatment of Alpha-Mannosidosis;Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases ...	Product Name: Lamazym Product Code: rhLAMAN INN or Proposed INN: Lamazym Other descriptive name: recomb ...	Zymenex A/S	NULL	Not Recruiting			Female: yes Male: yes	25	Phase 3	Spain;Denmark;Germany;Sweden;Belgium

First Previous1 2 3Next Last